Health Effects
Obesity is now recognized as one of America’s most serious and growing epidemics. As expected, the prevalence of numerous, adverse health conditions flowing from obesity has also increased. For some of...
View ArticleArchives
APRIL 2009 April 24, 2009 After planting garden, Michelle Obama skips out to Five Guys for a burger. First lady says she sneaks off to fun restaurants – washingtonpost.com MARCH 2009 March 31, 2009...
View ArticleFDA, Qnexa and Birth Defects
Since the FDA pried open the doors for Vivus and Orexigen to have a second bite at approval for their anti-obesity drugs, researchers and clinicians have seen some hope for approval on the horizon and...
View ArticleStudy Raises Prospect of Qnexa Approval
A study published December 7, 2011in the American Journal of Clinical Nutrition provides two-year data on the safety and effectiveness of Vivus Inc.’s drug candidate, Qnexa in patients with...
View ArticleVivus Inc. Announces Date for FDA AdCom; results of birth defect study
Vivus Inc. has announced that the FDA will hold an Advisory Committee meeting on February 22, 2012 for review of the obesity treatment, Qnexa. VIVUS, Inc. – VIVUS Announces Date of FDA Advisory...
View ArticleStudy Links Autism to Obesity, Diabetes
The increasing prevalence of autism spectrum disorders (ASD) has been both controversial and concerning to parents and health professionals. Could obesity and type 2 diabetes be responsible for some of...
View Article
